Patents by Inventor Terence A. Kelly

Terence A. Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Light scattering optical element for lighting applications
    Patent number: 12055748
    Abstract: An optical element with light scattering properties is configured for use in a light fixture or lighting module. When used in combination with a reflector or reflective surface proximate to an output face, the optical element can provide a range of non-Lambertian light distributions in alternative embodiments. The optical element utilizes combinations of dispersed light scattering particles and/or surface features to selectively scatter, disperse and internally reflect light. Using such optical arrangements it is possible to create light distributions with a single or multiple lobes or peak intensities and to control the position and shape of light distributions. The optical element is particularly suitable in low profile edge lit lighting assemblies used in indoor lighting products such as suspended, surface or recessed mounted linear light fixtures, ceiling mounted downlights, cove lights, and light fixtures for wall washing or perimeter lighting.
    Type: Grant
    Filed: April 24, 2023
    Date of Patent: August 6, 2024
    Assignee: Fusion Optix, Inc.
    Inventors: Terence Yeo, Timothy Kelly
  • Light fixture with edgelit optical element for direct downlighting applications
    Patent number: 12055747
    Abstract: A light fixture with edgelit optical element is configured with an elongate body which retains and aligns optical components in a shallow linear form factor. Embodiments can be installed within a ceiling grid system and provide a fixture height less than that of a ceiling grid T-bar. An edglit optical element with light scattering features produces an extended emitting area for low glare and provides light distributions such as asymmetric and symmetric batwing distributions particularly useful in downlighting and other lighting applications.
    Type: Grant
    Filed: March 11, 2022
    Date of Patent: August 6, 2024
    Assignee: Fusion Optix, Inc.
    Inventors: Terence Yeo, Timothy Kelly, Michael Demas
  • Compositions and methods for inhibiting kinases
    Patent number: 11725005
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: June 24, 2022
    Date of Patent: August 15, 2023
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • COMPOSITIONS AND METHODS FOR INHIBITING KINASES
    Publication number: 20230159514
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Application
    Filed: June 24, 2022
    Publication date: May 25, 2023
    Inventors: Milton H. Werner, Terence A. Kelly
  • Sorting by permutation
    Patent number: 11422805
    Abstract: A system such as a database management system determines a rule to impose sorted order upon a column without applying a sorting algorithm to the column and stores the rule to be applied to sort the column. In an embodiment, a permutation is the rule. The column, in an embodiment, is a column of a database table. In some cases, the rule is used to efficiently impose a correct sorted order on a subset of unsorted columns without the use of a sorting algorithm. In some cases, the rule is generated based at least in part on another column that is sorted using a sorting algorithm such as quicksort.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: August 23, 2022
    Assignee: Amazon Technologies, Inc.
    Inventors: Terence Kelly, Andrew Edward Caldwell, Carlos Garcia-Alvarado, Vijairam Parasuraman
  • Compositions and methods for inhibiting kinases
    Patent number: 11407747
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: January 5, 2021
    Date of Patent: August 9, 2022
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • COMPOSITIONS AND METHODS FOR INHIBITING KINASES
    Publication number: 20210130343
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Application
    Filed: January 5, 2021
    Publication date: May 6, 2021
    Inventors: Milton H. Werner, Terence A. Kelly
  • Compositions and methods for inhibiting kinases
    Patent number: 10906896
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: February 2, 2021
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • COMPOSITIONS AND METHODS FOR INHIBITING KINASES
    Publication number: 20200046699
    Abstract: The present invention provides methods for the prevention or treatment of Parkinson's Disease using Abelson-family tyrosine kinase inhibitors.
    Type: Application
    Filed: October 25, 2017
    Publication date: February 13, 2020
    Inventors: Milton H. Werner, Terence A. Kelly
  • COMPOSITIONS AND METHODS FOR INHIBITING KINASES
    Publication number: 20200031819
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Application
    Filed: June 26, 2019
    Publication date: January 30, 2020
    Inventors: Milton H. Werner, Terence A. Kelly
  • Compositions and methods for inhibiting kinases
    Patent number: 10344027
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: July 9, 2019
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Compositions and methods for inhibiting kinases
    Patent number: 10316031
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: June 11, 2019
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • COMPOSITIONS AND METHODS FOR INHIBITING KINASES
    Publication number: 20190119266
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Application
    Filed: October 24, 2018
    Publication date: April 25, 2019
    Inventors: Milton H. Werner, Terence A. Kelly
  • COMPOSITIONS AND METHODS FOR INHIBITING KINASES
    Publication number: 20190055234
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Application
    Filed: October 24, 2018
    Publication date: February 21, 2019
    Inventors: Milton H. WERNER, Terence A. Kelly
  • SMALL MOLECULE LFA-1 INHIBITORS
    Publication number: 20190040008
    Abstract: The present invention relates to novel compounds which are capable of inhibiting the interaction of LFA-1 with its counter ligands.
    Type: Application
    Filed: August 2, 2018
    Publication date: February 7, 2019
    Applicant: ALLOCYTE PHARMACEUTICALS AG
    Inventors: Werner BREITENSTEIN, Marianne HUERZELER, Terence KELLY, Riccardo MANCUSO, Gisbert SCHNEIDER, Gabriele WEITZ-SCHMIDT
  • Compositions and methods for inhibiting kinases
    Patent number: 10118923
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: November 6, 2018
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Small molecule LFA-1 inhibitors
    Patent number: 10077238
    Abstract: The present invention relates to novel compounds which are capable of inhibiting the interaction of LFA-1 with its counter ligands.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: September 18, 2018
    Assignee: ALLOCYTE PHARMACEUTICALS AG
    Inventors: Werner Breitenstein, Marianne Huerzeler, Terence Kelly, Riccardo Mancuso, Gisbert Schneider, Gabriele Weitz-Schmidt
  • COMPOSITIONS AND METHODS FOR INHIBITING KINASES
    Publication number: 20180057488
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Application
    Filed: November 7, 2017
    Publication date: March 1, 2018
    Inventors: Milton H. Werner, Terence A. Kelly
  • Compositions and methods for inhibiting kinases
    Patent number: 9828370
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: November 28, 2017
    Assignee: INHIBIKASE THERAPEUTICS, INC.
    Inventors: Milton H. Werner, Terence A. Kelly
  • SMALL MOLECULE LFA-1 INHIBITORS
    Publication number: 20170121284
    Abstract: The present invention relates to novel compounds which are capable of inhibiting the interaction of LFA-1 with its counter ligands.
    Type: Application
    Filed: June 10, 2015
    Publication date: May 4, 2017
    Applicant: ALLOCYTE PHARMACEUTICALS AG
    Inventors: Werner BREITENSTEIN, Marianne HUERZELER, Terence KELLY, Riccardo MANCUSO, Gisbert SCHNEIDER, Gabriele WEITZ-SCHMIDT